Literature DB >> 1911549

Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy.

R E O'Hehir1, H Yssel, S Verma, J E de Vries, H Spits, J R Lamb.   

Abstract

A failure of T lymphocytes to produce interleukin 2 (IL-2) on restimulation may, in part, account for the specific unresponsiveness that accompanies incomplete activation. The evidence to support this has been derived predominantly from the investigation of the molecular basis of anergy in murine type 1 T cells. In this study, the effects of different tolerogenic signals delivered by specific peptide or Staphylococcus aureus enterotoxin on the ability of antigen-specific human T cells to produce lymphokines, both in the induction phase and in established antigen-specific non-responsiveness, have been examined. Although T cell proliferation was decreased by supraoptimal concentrations of specific peptide in the presence or absence of antigen presenting cells, IL-2, IL-4, and interferon gamma (IFN-gamma) synthesis were comparable to that of activated T cells. The different tolerogenic signals, all capable of inhibiting phase of unresponsiveness. Restimulation of anergic T cells with an antigenic challenge failed to induce lymphokine production, with the exception of allergen-reactive T cells that secreted IFN-gamma. This latter observation is relevant to the desensitization of specific responsiveness in allergic disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911549     DOI: 10.1093/intimm/3.8.819

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  18 in total

Review 1.  The potential of peptide immunotherapy in allergy and asthma.

Authors:  F Runa Ali; A Barry Kay; Mark Larché
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

2.  Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction.

Authors:  D Strickland; U R Kees; P G Holt
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Regulation of cytokine production by human Th0 cells following stimulation with peptide analogues: differential expression of TGF-beta in activation and anergy.

Authors:  D C Tsitoura; C M Gelder; D M Kemeny; J R Lamb
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

4.  Presentation of peptides and proteins by intestinal epithelial cells.

Authors:  G F Hoyne; M G Callow; M C Kuo; W R Thomas
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

5.  T cell receptor genetics, autoimmunity and asthma.

Authors:  A J Frew; J Dasmahapatra
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

6.  Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

Authors:  V A Varney; Q A Hamid; M Gaga; S Ying; M Jacobson; A J Frew; A B Kay; S R Durham
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 7.  Novel approaches in immunotherapy.

Authors:  J M Saint-Remy
Journal:  Clin Rev Allergy       Date:  1994

8.  T-cell lymphokine response to orally administered proteins during priming and unresponsiveness.

Authors:  G F Hoyne; M G Callow; J Kuhlman; W R Thomas
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  T-cell responses to orally administered antigens. Study of the kinetics of lymphokine production after single and multiple feeding.

Authors:  G F Hoyne; W R Thomas
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

10.  The effects of changes at peptide residues contacting MHC class II T-cell receptor on antigen recognition and human Th0 cell effector function.

Authors:  J R Lamb; J A Higgins; C Hetzel; J D Hayball; R A Lake; R E O'Hehir
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.